ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins.

Hydrogels are very attractive delivery systems for hydrophilic macromolecules such as proteins and DNA because they provide a protective environment and allow control of diffusion by adjusting cross-link densities. Physically cross-linked hydrogels generated by rapid swelling upon exposure to an aqueous environment can be obtained from ABA triblock copolymers containing hydrophobic polyester A-blocks and hydrophilic polyether B-blocks. They provide an attractive alternative to chemically cross-linked systems since they allow incorporation of macromolecular drug substances under mild process conditions. Moreover, they show controlled degradation behavior and excellent biocompatibility. In this review the synthesis and characterization of ABA triblock copolymers from polyester hard segments and poly(ethylene oxide) [PEO] soft segments as well as their biological and degradation properties will be discussed. Their use as biodegradable drug delivery devices in the form of implants, micro- and nanospheres has attracted considerable interest especially for proteins and may provide an alternative to poly(lactide-co-glycolide).

[1]  J. M. Harris,et al.  Introduction to Biotechnical and Biomedical Applications of Poly(Ethylene Glycol) , 1992 .

[2]  G. Winter,et al.  Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[3]  H. Ravivarapu,et al.  Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. , 2000, Journal of pharmaceutical sciences.

[4]  Michel Vert,et al.  STRUCTURE – PROPERTY RELATIONSHIP IN THE CASE OF THE DEGRADATION OF MASSIVE ALIPHATIC POLY – (-HYDROXY ACIDS) IN AQUEOUS MEDIA, PART 1: DEGRADATION OF LACTIDE - GLYCOLIDE COPOLYMERS: PLA 37.5 GA 25 AND PLA 75 GA 25 , 1990 .

[5]  L. Youxin,et al.  Biodegradable block copolymer matrices for long-acting contraceptives with constant release. , 1992 .

[6]  H. Hopfenberg,et al.  Swelling‐controlled, constant rate delivery systems , 1978 .

[7]  Xiaohong Li,et al.  In Vitro Protein Release and Degradation of Poly-dl-lactide-poly(ethylene glycol) Microspheres with Entrapped Human Serum Albumin: Quantitative Evaluation of the Factors Involved in Protein Release Phases , 2004, Pharmaceutical Research.

[8]  Kazutoshi Nozaki,et al.  A biodegradable polymer as a cytokine delivery system for inducing bone formation , 2001, Nature Biotechnology.

[9]  A. Skoulios,et al.  Synthèse et caractérisation de copolymères séquencés polyoxyéthylène/poly-ε-caprolactone† , 1972 .

[10]  M Morlock,et al.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. Feijen,et al.  Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles , 2000, Pharmaceutical development and technology.

[12]  J. Kovarova,et al.  Microdomain structure in polylactide-block-poly(ethylene oxide) copolymer films. , 2000, Biomaterials.

[13]  M. Lück,et al.  Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Y. Lee,et al.  Hydrogels of poly(ethylene glycol)-co-poly(lactones) diacrylate macromers and β-chitin , 1997 .

[15]  Gerhard Winter,et al.  Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients , 1997 .

[16]  Hsin-Jiant Liu,et al.  Structural analysis and degradation behavior in polyethylene glycol/poly(L‐lactide) copolymers , 1994 .

[17]  D. Cohn,et al.  Morphological study of biodegradable PEO/PLA block copolymers. , 1987, Journal of biomedical materials research.

[18]  C. Xiong,et al.  Optimization of preparative conditions for poly-DL-lactide- polyethylene glycol microspheres with entrapped Vibrio cholera antigens. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[19]  K. Sakurai,et al.  PREPARATION AND CHARACTERIZATION OF POLYLACTIDE-POLY(ETHYLENE GLYCOL)-POLYLACTIDE TRIBLOCK POLYMERS AND A PRELIMINARY IN VIVO EXAMINATION OF THE BLOOD CIRCULATION TIME FOR THE NANOPARTICLES MADE THEREFROM , 1999 .

[20]  C. Xiong,et al.  Studies on the block copolymerization of D,L‐lactide and poly(ethyle glycol) with aluminium complex catalyst , 1995 .

[21]  T. Kissel,et al.  Monitoring Microviscosity and Microacidity of the Albumin Microenvironment Inside Degrading Microparticles from Poly(lactide-co-glycolide) (PLG) or ABA-triblock Polymers Containing Hydrophobic Poly(lactide-co-glycolide) A Blocks and Hydrophilic Poly(ethyleneoxide) B Blocks , 1998, Pharmaceutical Research.

[22]  K. Sakurai,et al.  Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(l-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo , 1998 .

[23]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[24]  K. Sakurai,et al.  Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro. , 1999, International journal of pharmaceutics.

[25]  K. Takaoka,et al.  Biodegradable Poly-d,l-Lactic Acid-Polyethylene Glycol Block Copolymers as a BMP Delivery System for Inducing Bone , 2001, The Journal of bone and joint surgery. American volume.

[26]  C. Xiong,et al.  Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. , 1999, International journal of pharmaceutics.

[27]  M. Paci,et al.  Polyether-polyester block copolymers by non-catalysed polymerization of ɛ-caprolactone with poly(ethylene glycol) , 1989 .

[28]  Kristi S. Anseth,et al.  Predicting Controlled-Release Behavior of Degradable PLA-b-PEG-b-PLA Hydrogels , 2001 .

[29]  D. Cohn,et al.  Compositional and structural analysis of PELA biodegradable block copolymers degrading under in vitro conditions. , 1989, Biomaterials.

[30]  J. Feijen,et al.  A versatile and highly efficient catalyst system for the preparation of polyesters based on lanthanide tris(2,6-di-tert-butylphenolate)s and various alcohols , 1996 .

[31]  Suming Li,et al.  Biodegradation of PLA/GA polymers: increasing complexity. , 1994, Biomaterials.

[32]  T. Park,et al.  Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. , 1998, Journal of microencapsulation.

[33]  J. Anderson,et al.  In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. , 1996, Journal of biomedical materials research.

[34]  Mattheus F. A. Goosen,et al.  Mechanism of lactide polymerization in the presence of stannous octoate: The effect of hydroxy and carboxylic acid substances , 1994 .

[35]  Kai Griebenow,et al.  Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability , 2000, Pharmaceutical Research.

[36]  K. Takaoka,et al.  Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[37]  T. Kissel,et al.  Microencapsulation of antigens using biodegradable polyesters: facts and phantasies. , 1997, Behring Institute Mitteilungen.

[38]  Robert Langer,et al.  Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 2004, Pharmaceutical Research.

[39]  I. Rashkov,et al.  Hydrolytic degradation of PLA/PEO/PLA triblock copolymers prepared in the presence of Zn metal or CaH2 , 1998 .

[40]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[41]  Mitch Jacoby.  CUSTOM-MADE BIOMATERIALS: Applying engineering, materials, and chemistry principles, researchers produce safe, smart, and effective implantable devices , 2001 .

[42]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[43]  Cees W. M. Bastiaansen,et al.  ABA Type Copolymers of Lactide with Poly(ethylene glycol). Kinetic, Mechanistic, and Model Studies , 1995 .

[44]  F. Bates,et al.  Polymer-Polymer Phase Behavior , 1991, Science.

[45]  H. Kricheldorf,et al.  Polylactones, 22 ABA triblock copolymers of L-lactide and poly(ethylene glycol)† , 1993 .

[46]  A. Klibanov,et al.  Protein stability in controlled-release systems , 2000, Nature Biotechnology.

[47]  D. Attwood,et al.  The Release of 5-Fluorouracil from a Swellable Matrix of a Triblock Copolymer of ε-Caprolactone and Ethylene Oxide , 1995, Pharmaceutical Research.

[48]  T. Kissel,et al.  The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression moulding of poly(lactide-co-glycolide) and ABA triblock copolymers. , 2000, Biomaterials.

[49]  E. Chiellini,et al.  Frontiers in biomedical polymer applications , 1998 .

[50]  T. Kissel,et al.  Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[51]  J. W. Gibson,et al.  New long-acting injectable microcapsule contraceptive system. , 1979, American journal of obstetrics and gynecology.

[52]  K. Takaoka,et al.  New synthetic absorbable polymers as BMP carriers: plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. , 1999, Journal of biomedical materials research.

[53]  Michel Vert,et al.  Synthesis, Characterization, and Hydrolytic Degradation of PLA/PEO/PLA Triblock Copolymers with Short Poly(l-lactic acid) Chains , 1996 .

[54]  A Apicella,et al.  Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. , 1993, Biomaterials.

[55]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[56]  T. Kissel,et al.  In-vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly (L(+) lactic acid), or poly(L(+) lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks , 1994 .

[57]  S. Li,et al.  Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type. , 2001, Biomaterials.

[58]  N. B. Graham,et al.  Hydrogels for controlled drug delivery. , 1984, Biomaterials.

[59]  Depu Chen,et al.  Lithium chloride as catalyst for the ring-opening polymerization of lactide in the presence of hydroxyl-containing compounds , 1999 .

[60]  T. Kissel,et al.  Biodegradable microspheres containing influenza A vaccine: immune response in mice. , 1999, Vaccine.

[61]  D. Cohn,et al.  Biodegradable PELA block copolymers: in vitro degradation and tissue reaction. , 1988, Biomaterials, artificial cells, and artificial organs.

[62]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[63]  T. Kissel,et al.  Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks , 1996 .

[64]  J. Feijen,et al.  Kinetics and mechanism of L-lactide polymerization using two different yttrium alkoxides as initiators , 1996 .

[65]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[66]  T. Kissel,et al.  Synthesis, characteristics and in vitro degradation of star-block copolymers consisting of l-lactide, glycolide and branched multi-arm poly(ethylene oxide) , 1998 .

[67]  Michel Vert,et al.  MORE ABOUT THE DEGRADATION OF LA/GA – DERIVED MATRICES IN AQUEOUS MEDIA , 1991 .

[68]  Yi-you Huang,et al.  Drug release from PLA/PEG microparticulates , 1997 .

[69]  P. Giusti,et al.  Block copolymers of L-lactide and poly(ethylene glycol) for biomedical applications , 1994 .

[70]  I. Lancranjan,et al.  Parenteral depot-systems on the basis of biodegradable polyesters , 1991 .

[71]  M. Sefton.  Biomaterials and Clinical Applications , 1988 .

[72]  Wim E. Hennink,et al.  Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles , 2000, Pharmaceutical Research.

[73]  H. Janeczek,et al.  Polymerization of lactones, 17. Synthesis of ethylene glycol‐L‐lactide block copolymers , 1993 .

[74]  T. Kissel,et al.  Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion? , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  B. Gander,et al.  Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives , 1998, Pharmaceutical Research.

[76]  David Shiaw-Guang Hu,et al.  Effect of soft segment on degradation kinetics in polyethylene glycol/poly(l-lactide) block copolymers , 1993 .

[77]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[78]  J. Feijen,et al.  Stereocomplex formation in ABA triblock copolymers of poly(lactide) (A) and poly(ethylene glycol) (B) , 1995 .

[79]  A. M. Reed,et al.  Biodegradable polymers for use in surgery—poly(ethylene oxide) poly(ethylene terephthalate) (PEO/PET) copolymers: 1 , 1979 .

[80]  S. Schwendeman,et al.  Stabilization of Proteins Encapsulated in Cylindrical Poly(lactide-co-glycolide) Implants: Mechanism of Stabilization by Basic Additives , 2000, Pharmaceutical Research.

[81]  T. Kissel,et al.  Branched biodegradable polyesters for parenteral drug delivery systems. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[82]  H. S. Kim,et al.  Thermal behaviour of poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) tri-block copolymers , 2001 .

[83]  M. Sarbolouki,et al.  Synthesis and Characterization of Novel ABA Triblock Copolymers from L-Lactide, Glycolide, and PEG , 1999 .

[84]  K. Zhu,et al.  Poly-DL-lactic acid: polyethylene glycol block copolymers. The influence of polyethylene glycol on the degradation of poly-DL-lactic acid. , 1994, Journal of biomaterials science. Polymer edition.

[85]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[86]  R. Barsacchi,et al.  The biodegradation of poly (ester-ether-ester) block copolymers in a cellular environmentin vitro , 1994 .

[87]  W. Hunter,et al.  Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study , 1996 .

[88]  T. Kissel,et al.  Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(l-lactic acid) or poly (l-lactic-co-glycolic acid) A-blocks attached to central poly ( oxyethylene ) B-blocks , 1993 .

[89]  James M. Anderson,et al.  Biocompatibility of ABA triblock copolymer microparticles consisting of poly(l-lactic-co-glycolic-acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection , 1997 .

[90]  T. Kissel,et al.  Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[91]  P. Giusti,et al.  Poly(ester-ether-ester) block copolymers as biomaterials , 1994 .

[92]  C. Xiong,et al.  Synthesis and characterization of block copolymers from D, L‐lactide and poly(ethylene glycol) with stannous chloride , 1990 .

[93]  M. Paci,et al.  Synthesis and characterization of polymers from β-propiolactone and poly(ethylene glycol)s , 1987 .

[94]  C. Cristallini,et al.  Degradation products of poly(ester-ether-ester) block copolymers do not alter endothelial metabolism in vitro , 1995 .

[95]  J. M. Harris,et al.  Poly(Ethylene Glycol) Chemistry , 1992 .

[96]  J. Feijen,et al.  Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers , 2000, Journal of drug targeting.

[97]  T. Kissel,et al.  Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems , 1992 .

[98]  M. Davies,et al.  XPS and SSIMS Analysis Revealing Surface Segregation and Short-Range Order in Solid Films of Block Copolymers of PEO and PLGA , 1997 .

[99]  Michel Vert,et al.  Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media , 1990 .

[100]  Michel Vert,et al.  Structure-property relationships in the case of the degradation of massive aliphatic poly-(α-hydroxy acids) in aqueous media , 1990 .

[101]  H. Okada,et al.  One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. , 1997, Advanced drug delivery reviews.